ASX:HLS Healius (HLS) Stock Price, News & Analysis → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free HLS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.33 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield4.46%Price TargetN/A Stock AnalysisStock Analysis Get Healius alerts: Email Address Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. About Healius Stock (ASX:HLS)Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.Read More Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. HLS Stock News HeadlinesMarch 19, 2024 | americanbankingnews.comHealius Limited (ASX:HLS) Insider Sally Evans Buys 16,450 Shares of StockMarch 17, 2024 | afr.comMaking excuses for weak margins has ended: Healius CEOMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 4, 2024 | marketwatch.comHealius Begins Strategic Review of Assets, Structure Under New CEOMarch 4, 2024 | fool.com.auBeaten-up ASX 200 stock jumps 14% on CEO resignationFebruary 27, 2024 | msn.comAustralia stocks higher at close of trade; S&P/ASX 200 up 0.13%November 29, 2023 | morningstar.comHealius Ltd HLSNovember 29, 2023 | fool.com.auHere's why you might have just bought Healius sharesMarch 28, 2024 | Behind the Markets (Ad)Central Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.November 27, 2023 | fool.com.auHealius share price rallies amid corporate resetNovember 26, 2023 | au.investing.comASX 200 update: Healius Chairwoman Jenny Macdonald to retireNovember 22, 2023 | morningstar.com.auThis equity raise looks extremely attractiveNovember 21, 2023 | msn.comTop 10 at 11: Boardroom battles and spinning drills are driving the market this morningNovember 21, 2023 | fool.com.auWhy are Healius shares crashing 35% on Wednesday?November 20, 2023 | fool.com.auWhy weren't Healius shares trading on the ASX today?October 31, 2023 | afr.comHealius LimitedOctober 26, 2023 | msn.comAustralia stocks lower at close of trade; S&P/ASX 200 down 0.04%September 1, 2023 | msn.comScoPo’s Powerplays: ASX health stocks rise as big names ‘trading at very attractive fundamentals’August 30, 2023 | fool.com.auHealius share price rises strongly despite 92% profit crash in FY23May 25, 2023 | uk.finance.yahoo.comHLS.AX - Healius LimitedApril 17, 2023 | afr.comTakeovers Panel declines to adjudicate on hostile Healius takeoverApril 7, 2023 | finance.yahoo.comWith 58% ownership of the shares, Healius Limited (ASX:HLS) is heavily dominated by institutional ownersApril 4, 2023 | msn.com50% upside: The small-cap ASX share that has everything going for itMarch 26, 2023 | afr.comHealius slings ACL bid to Takeovers PanelMarch 26, 2023 | afr.comWylie’s Tanarra Capital spoils ACL’s Healius buyout hopesMarch 20, 2023 | finance.yahoo.comHealius (ASX:HLS) shareholders notch a 13% CAGR over 3 years, yet earnings have been shrinkingMarch 19, 2023 | msn.comHealius share price jumps 7% on takeover approach from smaller rivalSee More Headlines Receive HLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/15/2019Today3/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:HLS CUSIPN/A CIKN/A Webwww.primaryhealthcare.com.au Phone61 2 9432 9400FaxN/AEmployees10,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($1.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.94Net Income$-984,100,000.00 Net Margins-57.63% Pretax MarginN/A Return on Equity-68.02% Return on Assets1.31% Debt Debt-to-Equity Ratio153.80 Current Ratio0.53 Quick Ratio0.47 Sales & Book Value Annual Sales$1.69 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow12.26 Book ValueA$1.45 per share Price / BookN/AMiscellaneous Outstanding Shares726,100,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.65 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Paul D. AndersonMD, Group CFO, CEO & DirectorMr. John McKechnieAdvisorDr. Jan Van RooyenHead & Group Executive of Healius PathologyDr. Phil LucasChief Executive of Lumus ImagingIan McphanChief Operating Officer of Healius PathologySharon NgHead of Group FP&AMs. Mary Ellen Weaver AGIACompany SecretaryDr. John HoustonAdvisorMore ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersSally EvansBought 16,450 shares on 3/15/2024Total: $25,004.00 ($1.52/share)Maxine JaquetSold 512,645 sharesTotal: $1.50 M ($2.93/share)Maxine JaquetSold 1,667,805 sharesTotal: $2.33 M ($1.40/share)Charlie TaylorBought 50,000 shares on 12/21/2023Total: $74,500.00 ($1.49/share)Charlie TaylorBought 50,000 shares on 12/19/2023Total: $74,800.00 ($1.50/share) HLS Stock Analysis - Frequently Asked Questions How were Healius' earnings last quarter? Healius Limited (ASX:HLS) announced its quarterly earnings results on Friday, February, 15th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.09 by $0.06. Healius had a negative net margin of 57.63% and a negative trailing twelve-month return on equity of 68.02%. Is Healius a good dividend stock? Healius (ASX:HLS) pays an annual dividend of A$0.12 per share and currently has a dividend yield of 4.46%. HLS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for HLS. What other stocks do shareholders of Healius own? Based on aggregate information from My MarketBeat watchlists, some companies that other Healius investors own include BetaShares Crude Oil Index ETF Currency Hedged (Synthetic) (OOO), Neometals (NMT), Magellan High Conviction Trust (MHH), Helloworld Travel (HLO), Flight Centre Travel Group (FLT), Beach Energy (BPT), Bank of Queensland (BOQ), Australis Oil & Gas (ATS), ANZ Group (ANZ) and Aeris Environmental (AEI). This page (ASX:HLS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Healius Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.